These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35427563)

  • 61. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Experimental transmission of Leishmania (Leishmania) amazonensis to immunosuppressed mice through the bite of Lutzomyia longipalpis (Diptera: Psychodidae) results in cutaneous leishmaniasis.
    Silva RCRD; Cruz LNPD; Coutinho JMDS; Fonseca-Alves CE; Rebêlo JMM; Pereira SRF
    Rev Inst Med Trop Sao Paulo; 2021; 63():e81. PubMed ID: 34878039
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of in vivo depletion of CD4+ T cells on experimental infection of susceptible BALB/c mice with Leishmania amazonensis.
    Silva EM; Bertho AL; Mendonça SC
    Acta Trop; 1994 Feb; 56(1):111-20. PubMed ID: 7911268
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Action of pentoxifylline on experimental cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis.
    de Sá Oliveira T; Capp Neto M; Martins BJ; Rodrigues HA; Antonino RM; Magalhães AV
    Mem Inst Oswaldo Cruz; 2000; 95(4):477-82. PubMed ID: 10904402
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment with triterpenic fraction purified from Baccharis uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice.
    Yamamoto ES; Campos BL; Laurenti MD; Lago JH; Grecco Sdos S; Corbett CE; Passero LF
    Parasitol Res; 2014 Jan; 113(1):333-9. PubMed ID: 24173812
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of pentostam and cimetidine on the development of leishmaniasis (Leishmania mexicana amazonensis) and concomitant malaria (Plasmodium yoelii).
    Coleman RE; Edman JD; Semprevivo LH
    Ann Trop Med Parasitol; 1989 Aug; 83(4):339-44. PubMed ID: 2557804
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.
    Francesquini FC; Silveira FT; Passero LF; Tomokane TY; Carvalho AK; Corbett CE; Laurenti MD
    Int J Exp Pathol; 2014 Dec; 95(6):418-26. PubMed ID: 25476864
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of oral treatment with the essential oil from Chenopodium ambrosioides against cutaneous leishmaniasis in BALB/c mice, caused by Leishmania amazonensis.
    Monzote L; García M; Montalvo AM; Linares R; Scull R
    Forsch Komplementmed; 2009 Oct; 16(5):334-8. PubMed ID: 19887812
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nanoscaled hydrated antimony (V) oxide as a new approach to first-line antileishmanial drugs.
    Franco AM; Grafova I; Soares FV; Gentile G; Wyrepkowski CD; Bolson MA; Sargentini É; Carfagna C; Leskelä M; Grafov A
    Int J Nanomedicine; 2016; 11():6771-6780. PubMed ID: 28008252
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The pentavalent antimonial therapy against experimental Leishmania amazonensis infection is more effective under the inhibition of the NF-κB pathway.
    Macedo SR; de Figueiredo Nicolete LD; Ferreira Ados S; de Barros NB; Nicolete R
    Int Immunopharmacol; 2015 Sep; 28(1):554-9. PubMed ID: 26218282
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana.
    Aguilar Torrentera F; Lambot MA; Laman JD; Van Meurs M; Kiss R; Noël JC; Carlier Y
    Am J Trop Med Hyg; 2002 Mar; 66(3):273-9. PubMed ID: 12139220
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice.
    Kalat SA; Khamesipour A; Bavarsad N; Fallah M; Khashayarmanesh Z; Feizi E; Neghabi K; Abbasi A; Jaafari MR
    Exp Parasitol; 2014 Aug; 143():5-10. PubMed ID: 24780938
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dietary Vitamin D3 Deficiency Increases Resistance to
    Bezerra IPDS; Oliveira-Silva G; Braga DSFS; de Mello MF; Pratti JES; Pereira JC; da Fonseca-Martins AM; Firmino-Cruz L; Maciel-Oliveira D; Ramos TD; Vale AM; Gomes DCO; Rossi-Bergmann B; de Matos Guedes HL
    Front Cell Infect Microbiol; 2019; 9():88. PubMed ID: 31024859
    [TBL] [Abstract][Full Text] [Related]  

  • 74. FVB/NJ strain as a mouse model for cutaneous leishmaniasis by Leishmania (L.) amazonensis.
    Carrara GMP; Stolf BS
    Mem Inst Oswaldo Cruz; 2024; 119():e230182. PubMed ID: 38511814
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ocular experimental leishmaniasis in C57BL/10 and BALB/c mice induced by Leishmania amazonensis infection.
    Calabrese KS; Silva LS; Hardoim DJ; Souza CS; Abreu-Silva AL
    Exp Parasitol; 2013 Feb; 133(2):156-61. PubMed ID: 23201219
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 77. M1 homeopathic complex trigger effective responses against Leishmania (L) amazonensis in vivo and in vitro.
    Nascimento KF; de Santana FR; da Costa CRV; Kaplum V; Volpato H; Nakamura CV; Bonamin LV; de Freitas Buchi D
    Cytokine; 2017 Nov; 99():80-90. PubMed ID: 28738234
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.
    Duarte MC; Lage DP; Martins VT; Costa LE; Carvalho AMRS; Ludolf F; Santos TTO; Vale DL; Roatt BM; Menezes-Souza D; Fernandes AP; Tavares CAP; Coelho EAF
    Immunobiology; 2017 Feb; 222(2):251-260. PubMed ID: 27693018
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modulation of inflammation response to murine cutaneous Leishmaniasis by homeopathic medicines: Antimonium crudum 30cH.
    Rodrigues de Santana F; de Paula Coelho C; Cardoso TN; Perez Hurtado EC; Roberti Benites N; Dalastra Laurenti M; Villano Bonamin L
    Homeopathy; 2014 Oct; 103(4):264-74. PubMed ID: 25439043
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biological behavior of Leishmania (L.) amazonensis isolated from a human diffuse cutaneous leishmaniasis in inbred strains of mice.
    Cupolilo SM; Souza CS; Abreu-Silva AL; Calabrese KS; Goncalves da Costa SC
    Histol Histopathol; 2003 Oct; 18(4):1059-65. PubMed ID: 12973675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.